Immune to Cancer: The CRI Blog
-
Ovarian Cancer Awareness Month: How Immunotherapy Fights This High-Occurrence Malignancy
Ovarian cancer is one of several gynecologic malignancies, impacting about 300,000 women globally each year. September has… -
5 Things to Know if You Missed CICON24
CICON24 wrapped up on September 11, 2024, at the Gaylord National Resort and Convention Center in National… -
Supercharging T Cells to Fight Cancer: A Revolutionary Discovery
In the battle against cancer, our immune system’s T cells are frontline soldiers, designed to seek out… -
CICON24 Day 4 Recap: Pioneering Cellular Therapies and Cancer Vaccines Shape the Future of Cancer Treatment
Led by inaugural CRI Lloyd J. Old STAR, Yvonne Chen, PhD, from UCLA, day four of CICON24… -
CICON24 Day 3 Recap: Advances in T Cell Tolerance, Metabolism, and the Microbiome in Cancer Immunotherapy
Day three of CICON24 continued the momentum of the previous days with an impressive lineup of talks… -
CICON24 Day 2 Recap: Exploring Cancer Vaccines, Immune Health, and Future Therapies
NATIONAL HARBOR —Day two of CICON24 began with an impactful keynote by Cathy Wu, MD, from Dana… -
Introducing Dr. Alicia Zhou: A New Chapter in Leadership at the Cancer Research Institute
The Cancer Research Institute (CRI) is excited to announce a transformative moment in its history with the… -
CICON24 Day 1 Recap: Groundbreaking Research and Collaboration Driving the Future of Cancer Immunotherapy
NATIONAL HARBOR — CICON24 officially kicked off today at the Gaylord National Resort and Convention Center in… -
Prostate Cancer Awareness Month: Unlocking the Power of Immunotherapy to Combat a Common Men’s Cancer
Prostate cancer is the second most common for men, only trailing skin cancer. Approximately 1.3 million men…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.